Results 31 to 40 of about 347,948 (362)

Post Autologous Stem Cell Transplantation Complication Management in Case of Malignant Lymphoma Patients

open access: yesJournal of Interdisciplinary Medicine, 2017
Introduction: Autologous hematopoietic stem cell transplantation (ASCT) represents a standard therapy in the management of hematologic malignancies such as malignant lymphomas and has used for approximately three decades.
Pakucs Annamária   +8 more
doaj   +1 more source

Histogram of Cell Types: Deep Learning for Automated Bone Marrow Cytology [PDF]

open access: yesarXiv, 2021
Bone marrow cytology is required to make a hematological diagnosis, influencing critical clinical decision points in hematology. However, bone marrow cytology is tedious, limited to experienced reference centers and associated with high inter-observer variability.
arxiv  

The Evolution of Intracardiac Hemodynamics Post Autologous Stem Cell Transplant in a Case of Multiple Myeloma Associated with Severe Tricuspid and Mitral Valve Insufficiency

open access: yesJournal of Interdisciplinary Medicine, 2017
Stem cells are undifferentiated cells that can divide and become differentiated. Hematopoietic stem cells cannot transform into new stem cells such as cardiomyocytes or new heart valves, but they act through paracrine effects, by secreting cytokines and ...
Tudor Cezara-Iuliana   +8 more
doaj   +1 more source

Differentiation of metastatic lesions to the bones and multiple myeloma – a case study

open access: yesJournal of Education, Health and Sport, 2020
Bones are one of the most common locations for cancer metastasis. Foci, which are in the most cases osteolytic, are located in the spine, ribs, pelvis, long bones.
Olaf Pachciński   +5 more
doaj   +1 more source

Leukemia with Plasma Cells — Case Report

open access: yesJournal of Interdisciplinary Medicine, 2017
Plasma cell leukemia (PCL) is one of the most aggressive monoclonal gammopathies, being characterized by the presence of more than 20% of plasma cells in the peripheral blood and an absolute number of these cells of more than 2×109, with different ...
Benedek István   +6 more
doaj   +1 more source

A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients

open access: yesBMC Cancer, 2020
Background Classical MPNs including ET and PMF have a chronic course and potential for leukaemic transformation. Timely diagnosis is obligatory to ensure appropriate management and positive outcomes.
Uzma Zaidi   +9 more
doaj   +1 more source

Implementation and Evaluation of a Multivariate Abstraction-Based, Interval-Based Dynamic Time-Warping Method as a Similarity Measure for Longitudinal Medical Records [PDF]

open access: yes, 2021
We extended dynamic time warping (DTW) into interval-based dynamic time warping (iDTW), including (A) interval-based representation (iRep): [1] abstracting raw, time-stamped data into interval-based abstractions, [2] comparison-period scoping, [3] partitioning abstract intervals into a given temporal granularity; (B) interval-based matching (iMatch ...
arxiv   +1 more source

Unrelated Allogeneic Stem Cell Transplantation in a Patient with Chronic Myeloid Leukemia in Blast Crisis

open access: yesJournal of Interdisciplinary Medicine, 2017
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder, which can involve the hematopoietic stem cell or early progenitor cells, without the loss of their capacity to differentiate.
Benedek István   +6 more
doaj   +1 more source

The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation

open access: yesBMC Cancer, 2021
Background Isocitrate dehydrogenase (IDH1/2) gene mutations are the most frequently observed mutations in cartilaginous tumors. The mutant IDH causes elevation in the levels of R-enantiomer of 2-hydroxylglutarate (R-2HG). Mesenchymal stromal cells (MSCs)
Lizhen Liu   +9 more
doaj   +1 more source

CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results

open access: yesFrontiers in Oncology, 2023
BackgroundPatients with refractory/relapsed (r/r) acute B lymphocytic leukemia (B-ALL) can achieve complete response (CR) after chimeric antigen receptor T-cell (CAR-T) therapy, but recurrence occurs in the short term.
Zhihui Li   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy